Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Uralbiopharm is one of the oldest pharmaceutical manufacturers in the Ural region of Russia, founded in 1930 and headquartered in Yekaterinburg. The company specializes in the production of traditional, affordable generic medicines, over-the-counter (OTC) drugs, and dietary supplements. Its product portfolio includes well-known regional brands such as Pentaflycin, a combined medication for cold and flu symptoms, as well as essential medicines like paracetamol and activated carbon. Uralbiopharm operates GMP-compliant manufacturing facilities capable of producing tablets, capsules, and sachet packs, and it offers contract manufacturing services to external partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Uralbiopharm.